Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Some drugs used to treat immune conditions may cause different types of hair loss.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

DHT, a testosterone byproduct, causes male pattern baldness.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.